Bcr-Abl expression in either T-ALL or B-ALL cells triggers an IKK-dependent activation of NF-κB that is crucial to the pathogenicity of Philadelphia positive (Ph+) leukemias [25]. The gene discussed is NFKB1; the disease is acute lymphoblastic leukemia.